Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues.
Ethacrynic acid [2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxyl] acetic acid, is a water-soluble diuretic agent that has been shown to potentiate the in vitro cytotoxicity of chemotherapeutic agents in established cell lines. We used the differential staining cytotoxicity (DiSC) assay to determine whether ethacrynic acid at 1 and 3.3 microM would potentiate the cytotoxicity of nitrogen mustard and/or doxorubicin in primary cultures of hematologic neoplasms from heavily pretreated patients and in normal peripheral blood lymphocytes. At 3.3 microM, ethacrynic acid was toxic to 8 of 24 (33%) tumor specimens studied. In subsequent studies, ethacrynic acid at 1 microM was toxic to only 2 of 54 (4%) tumor specimens. Significant enhancement for doxorubicin or nitrogen mustard was confined to lymphatic malignancies and to normal peripheral blood lymphocytes. Interspecimen variability was observed, with no enhancement in most individual specimens, 2-fold enhancement in some specimens, and 4-fold enhancement in occasional specimens. Clinical trials will be required to determine whether the observed in vitro activity for ethacrynic acid is associated with clinical benefit in unselected or assay-selected patients.
Nagourney
R A
RA
Oncotech Inc., Irvine CA 92714.
Messenger
J C
JC
Kern
D H
DH
Weisenthal
L M
LM
D002470:Cell Survival / Q000187:drug effects; D004317:Doxorubicin / Q000494:pharmacology*; D004354:Drug Screening Assays, Antitumor / Q000379:methods; D004357:Drug Synergism; D004976:Ethacrynic Acid / Q000494:pharmacology*; D006801:Humans; D007938:Leukemia / Q000473:pathology; D008214:Lymphocytes / Q000187:drug effects / Q000473:pathology; D008223:Lymphoma / Q000473:pathology; D008466:Mechlorethamine / Q000494:pharmacology*; D013194:Staining and Labeling; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000473:pathology
D008466:Mechlorethamine; D004317:Doxorubicin; D004976:Ethacrynic Acid